An experimental study found that the expression of IMP2 was significantly increased in GBM, and further studies showed that IMP2 could regulate the PI3K/Akt signalling pathway by regulating IGF2 activity and promote the proliferation and invasion of GBM cells [40]. The gene discussed is IGF2BP2; the disease is glioblastoma.